Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To test the vasoactive and anti-inflammatory effects of prasugrel in patients with acute
coronary syndrome endothelial function -as a surrogate parameter of NO bioavailability- and
different markers of inflammation, oxidative stress and platelet activation will be assessed
in patients with unstable angina.